By acting as an endogenous inhibitor of TGF-β, DCN attenuates ECM deposition and fibrosis in myocardial infarction (Weis et al., 2005) and glomerulonephritis models (Border et al., 1992). The gene discussed is TGFB1; the disease is glomerulonephritis.